Manufacturing. Margin, capex and the shop floor.

R&D, the patent box and capital allowances aren't a tick-box exercise — they're a serious cash flow when claimed well and a serious problem when claimed badly. We focus on a smaller number of defensible claims with clear technical narratives, clean cost categorisation and contemporaneous evidence.

• R&D tax relief under the merged scheme
• Enhanced R&D-intensive SME claims where applicable
• Patent box election, streaming and benefit calculation
• Capital allowances reviews on plant and integral features
• Full expensing and AIA optimisation

Standard costing, BOM accuracy and per-product gross margins — reviewed against operational data so commercial decisions on pricing, product mix and capex are made on numbers the leadership team actually trusts. Most manufacturing finance functions inherit a chart of accounts that hides the answer; we help rebuild it.

Capex appraisal, post-investment review and the financing options — leasing, hire purchase, grants and asset-based lending — modelled with the tax position baked in. We've seen too many capex decisions made on payback alone; we widen the lens.

Post-Brexit supply chains, customs warehousing, inward and outward processing relief, and the VAT treatment of cross-border supplies — handled in concert with the operations team rather than after the import has cleared.

Family-owned manufacturers and PE-backed groups both reach a point where structure and ownership need a fresh look. We work through the options — MBO, trade sale, EOT, refinancing — with the same partner who's already auditing the business.